Market revenue in 2023 | USD 527.5 million |
Market revenue in 2030 | USD 1,033.4 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.54% in 2023. Horizon Databook has segmented the Italy cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The cell culture market in Italy is driven by various factors that contribute to its growth and development. Key players in the country’s cell culture market include Euroclone, Merck KGaA, Bio-Rad Laboratories, Thermo Fisher Scientific, Sartorius, Eppendorf, & others. One key factor is the robust biopharmaceutical sector in the country. Italy is home to multinational pharmaceutical companies and local biotech firms that rely on cell culture techniques to produce biologics.
With the increasing demand for biopharmaceutical products, the market for cell culture technologies, products, and services continues to expand. Furthermore, in the recent past, the Italian biotech industry exhibited notable growth due to tremendous academic & industrial research. Milan is the hub of the biotech sector in Italy, housing approximately 35% of all biotech companies.
Furthermore, in February 2020, an Italybased company, AurorA-TT, in collaboration with drug discovery companies Italfarmaco & Rottapharm Biotech, launched the biotech investment enterprise AurorA. This enterprise aims to aid early-stage biotechnology companies in any area of unmet medical needs. Thus, the growing biotechnology sector in the country and increasing R&D investments for the development of novel therapies are anticipated to create a favorable environment for cell culture market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Italy cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account